Older patients with schizophrenia: Challenges in the coming decades

被引:63
作者
Palmer, BW
Heaton, SC
Jeste, DV
机构
[1] Vet Affairs San Diego Healthcare Syst, Geriatr Psychiat Intervent Res Ctr 116A1, San Diego, CA 92161 USA
[2] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA
[3] San Diego Vet Affairs Med Ctr, Psychiat Serv, San Diego, CA USA
关键词
D O I
10.1176/ps.50.9.1178
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The number and proportion of older adults with schizophrenia will increase considerably in the coming decades, Although a vast literature on schizophrenia among younger adults exists, much less is known. about late-life schizophrenia and its treatment. The authors describe two potential scenarios for 2011, the year that the first baby boomers will turn 65. To ensure that the more favorable scenario becomes a reality, the authors suggest four goals: decrease medical comorbidity and mortality among younger patients with schizophrenia and improve their access to health care so that they can live longer and more productive lives; improve our understanding of the neurobiological and psychosocial factors underlying late-life schizophrenia, as well as the health care and social service needs of such patients; develop more effective and safer pharmacologic, psychosocial, and cognitive behavioral treatments; and improve rehabilitation of older people with schizophrenia. Specific strategies to foster these goals include establishing a consortium for studies of late-life schizophrenia; conducting multicenter studies of treatment effectiveness; and forming interdisciplinary collaborations among researchers, clinicians, government and industry representatives, and patient advocacy groups.
引用
收藏
页码:1178 / 1183
页数:6
相关论文
共 64 条
[1]  
American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, P5
[2]  
[Anonymous], RES INV PERS MENT DI
[3]  
[Anonymous], 1998, BEAUTIFUL MIND
[4]   Brain monoaminergic and neuropeptidergic variations in human aging [J].
Arranz, B ;
Blennow, K ;
Ekman, R ;
Eriksson, A ;
Mansson, JE ;
Marcusson, J .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (1-2) :101-115
[5]  
BARCLAY RM, 1971, KRAEPELIN DEMENTIA P
[6]  
Bleuler M., 1978, SCHIZOPHRENIC DISORD
[7]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[8]   SCHIZOPHRENICS KILL THEMSELVES TOO - A REVIEW OF RISK-FACTORS FOR SUICIDE [J].
CALDWELL, CB ;
GOTTESMAN, II .
SCHIZOPHRENIA BULLETIN, 1990, 16 (04) :571-589
[9]   CATAMNESTIC LONG-TERM STUDY ON THE COURSE OF LIFE AND AGING OF SCHIZOPHRENICS [J].
CIOMPI, L .
SCHIZOPHRENIA BULLETIN, 1980, 6 (04) :606-618
[10]   OUTCOME OF SCHIZOPHRENIA INTO LATER LIFE - AN OVERVIEW [J].
COHEN, CI .
GERONTOLOGIST, 1990, 30 (06) :790-797